Department of Epidemiology, College of Human Medicine, Michigan State University, East Lansing, USA.
BMC Public Health. 2010 Mar 23;10:152. doi: 10.1186/1471-2458-10-152.
Epidemiological studies show wide variability in the occurrence of cannabis smoking and related disorders across countries. This study aims to estimate cross-national variation in cannabis users' experience of clinically significant cannabis-related problems in three countries of the Americas, with a focus on cannabis users who may have tried alcohol or tobacco, but who have not used cocaine, heroin, LSD, or other internationally regulated drugs.
Data are from the World Mental Health Surveys Initiative and the National Latino and Asian American Study, with probability samples in Mexico (n = 4426), Colombia (n = 5,782) and the United States (USA; n = 8,228). The samples included 212 'cannabis only' users in Mexico, 260 in Colombia and 1,724 in the USA. Conditional GLM with GEE and 'exact' methods were used to estimate variation in the occurrence of clinically significant problems in cannabis only (CO) users across these surveyed populations.
The experience of cannabis-related problems was quite infrequent among CO users in these countries, with weighted frequencies ranging from 1% to 5% across survey populations, and with no appreciable cross-national variation in general. CO users in Colombia proved to be an exception. As compared to CO users in the USA, the Colombia smokers were more likely to have experienced cannabis-associated 'social problems' (odds ratio, OR = 3.0; 95% CI = 1.4, 6.3; p = 0.004) and 'legal problems' (OR = 9.7; 95% CI = 2.7, 35.2; p = 0.001).
This study's most remarkable finding may be the similarity in occurrence of cannabis-related problems in this cross-national comparison within the Americas. Wide cross-national variations in estimated population-level cumulative incidence of cannabis use disorders may be traced to large differences in cannabis smoking prevalence, rather than qualitative differences in cannabis experiences. More research is needed to identify conditions that might make cannabis-related social and legal problems more frequent in Colombia than in the USA.
流行病学研究表明,各国之间大麻吸食和相关障碍的发生存在广泛差异。本研究旨在评估三个美洲国家的大麻使用者经历临床显著的大麻相关问题的跨国差异,重点关注那些可能尝试过酒精或烟草但未使用可卡因、海洛因、LSD 或其他国际管制药物的大麻使用者。
数据来自世界心理健康调查倡议和国家拉丁裔和亚裔美国人研究,采用墨西哥(n=4426)、哥伦比亚(n=5782)和美国(n=8228)的概率样本。样本包括墨西哥的 212 名“仅大麻”使用者、哥伦比亚的 260 名和美国的 1724 名。采用条件广义线性模型和 GEE 以及“精确”方法来估计这些被调查人群中仅大麻使用者(CO)出现临床显著问题的发生率的变化。
这些国家的 CO 使用者经历大麻相关问题的情况相当罕见,加权频率在不同调查人群中从 1%到 5%不等,且总体上没有明显的跨国差异。哥伦比亚的 CO 使用者是一个例外。与美国的 CO 使用者相比,哥伦比亚的吸烟者更有可能经历与大麻相关的“社会问题”(优势比,OR=3.0;95%置信区间,CI=1.4,6.3;p=0.004)和“法律问题”(OR=9.7;95%CI=2.7,35.2;p=0.001)。
本研究最显著的发现可能是在美洲的跨国比较中,大麻相关问题的发生情况相似。大麻使用障碍的估计人群水平累积发生率的广泛跨国差异可能归因于大麻吸烟率的巨大差异,而不是大麻使用体验的质的差异。需要进一步研究以确定哪些条件可能使哥伦比亚的大麻相关社会和法律问题比美国更频繁。